Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,690Revenue $M6,418Net Margin (%)2.4Z-Score3.2
Enterprise Value $M10,477EPS $1.4Operating Margin %6.9F-Score6
P/E(ttm))59.5Cash Flow Per Share $3.3Pre-tax Margin (%)4.9Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %-0.5Quick Ratio1.2Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %3.3Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow10.8y-y EBITDA Growth Rate %31.3ROA % (ttm)2.5Higher Current Ratio y-yN
Dividend Yield %0.9Insider Buy (3m)1ROE % (ttm)6.0Less Shares Outstanding y-yY
Payout Ratio %45.0Shares Outstanding M96.9ROI % (ttm)4.0Gross Margin Increase y-yN

Gurus Latest Trades with OCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OCRJoel Greenblatt 2014-12-31 Sold Out -0.31%$60.42 - $73.73
($68.02)
$ 89.8524%Sold Out0
OCRJoel Greenblatt 2014-09-30 Add0.28%$61.43 - $66.49
($63.51)
$ 89.8529%Add 929.98%501,043
OCRJoel Greenblatt 2014-06-30 Add0.04%$57.54 - $66.51
($62.07)
$ 89.8531%Add 1336.68%48,646
OCRJoel Greenblatt 2014-03-31 Reduce-0.01%$56.55 - $64.54
($60.65)
$ 89.8532%Reduce -71.62%3,386
OCRWallace Weitz 2013-12-31 Sold Out -0.24%$53.81 - $60.39
($57.24)
$ 89.8536%Sold Out0
OCRJoel Greenblatt 2013-12-31 Reduce-0.14%$53.81 - $60.39
($57.24)
$ 89.8536%Reduce -86.30%11,932
OCRWallace Weitz 2013-09-30 Reduce-1.19%$47.68 - $56.28
($53.39)
$ 89.8541%Reduce -84.78%113,700
OCRJean-Marie Eveillard 2013-09-30 Reduce-0.16%$47.68 - $56.28
($53.39)
$ 89.8541%Reduce -55.65%851,300
OCRJoel Greenblatt 2013-09-30 Buy 0.16%$47.68 - $56.28
($53.39)
$ 89.8541%New holding87,071
OCRWallace Weitz 2013-06-30 Reduce-1.37%$40.82 - $47.97
($44.74)
$ 89.8550%Reduce -52.62%746,920
OCRHOTCHKIS & WILEY 2013-06-30 Sold Out -0.29%$40.82 - $47.97
($44.74)
$ 89.8550%Sold Out0
OCRJoel Greenblatt 2013-06-30 Sold Out -0.25%$40.82 - $47.97
($44.74)
$ 89.8550%Sold Out0
OCRJoel Greenblatt 2013-03-31 Buy 0.25%$36.1 - $40.72
($38.52)
$ 89.8557%New holding122,850
OCRHOTCHKIS & WILEY 2012-12-31 Reduce-0.03%$32.98 - $36.59
($34.83)
$ 89.8561%Reduce -9.79%1,435,189
OCRJoel Greenblatt 2012-12-31 Sold Out -0.02%$32.98 - $36.59
($34.81)
$ 89.8561%Sold Out0
OCRJames Barrow 2012-12-31 Reduce$32.98 - $36.59
($34.83)
$ 89.8561%Reduce -0.06%3,965,780
OCRJoel Greenblatt 2012-09-30 Reduce-0.1%$30.68 - $35.53
($32.29)
$ 89.8564%Reduce -80.66%10,660
OCRJoel Greenblatt 2012-06-30 Buy 0.13%$29.5 - $36.01
($33.2)
$ 89.8563%New holding55,131
OCRHOTCHKIS & WILEY 2012-03-31 Add0.23%$32.51 - $35.56
($31.82)
$ 89.8565%Add 374.68%1,376,484
OCRJoel Greenblatt 2012-03-31 Sold Out -0.2%$32.51 - $35.56
($31.82)
$ 89.8565%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HEYER STEVEN JDirector 2015-03-05Buy6,630$75.4616.79view
Wallman AmyDirector 2015-03-02Sell1,874$77.4413.8view
Wallman AmyDirector 2014-08-20Sell5,672$63.8438.05view
Kraft Robert O.SVP & CFO 2014-05-06Buy1,500$6046.88view
Sahney NitinPresident & COO 2014-04-30Buy10,000$58.4950.68view
Sahney NitinPresident & COO 2014-04-30Buy10,000$58.4950.68view
Carpenter Randall ASVP and CIO 2013-05-24Sell17,587$45.8592.21view
Stamps Jeffrey MEVP & President, LTC Ops 2012-11-05Sell40,560$35.36149.24view
Sahney NitinCOO & President, SCG 2012-08-03Buy10,000$32175.41view
Workman John LInterim CEO, President & CFO 2012-07-30Buy5,000$31.14183.01view

Press Releases about OCR :

    Quarterly/Annual Reports about OCR:

    News about OCR:

    Articles On GuruFocus.com
    phone Dec 18 2014 
    It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 
    Steven Romick’s Third Quarter Sells at FPA Crescent Fund Oct 17 2013 
    Waiting for Gold Rain, Wally Weitz Does "Unnaturally Well" Sep 23 2013 
    First Pacific Advisors’ Major Selling and Reductions in Second Quarter Aug 15 2013 
    Steven Romick Comments on Omnicare Jul 29 2013 
    Steven Romick on WealthTrack Oct 20 2012 
    Weekly CEO Buys Highlight: SYMC, TDY, PNK, FNFG, OCR Aug 04 2012 
    Weitz Partners Value Fund Commentary: CVS, TGT, BRK.A, BRK.B Nov 11 2011 
    Daily Dividend Report: HNZ, OCR, SEIC, FPTB, EDE, FISI May 26 2011 

    More From Other Websites
    10-Q for Omnicare, Inc. May 01 2015
    Five things you need to know today, and the UPS dude who broke my heart May 01 2015
    Omnicare Draws Interest From CVS and Express Scripts Apr 30 2015
    Omnicare draws buyout interest from CVS, Express Scripts - Bloomberg Apr 30 2015
    Omnicare Said to Draw Interest From CVS and Express Scripts Apr 30 2015
    Omnicare (OCR) Q1 Earnings, Sales Top Estimates; Rise Y/Y - Analyst Blog Apr 30 2015
    Omnicare Inc Earnings Call scheduled for 9:00 am ET today Apr 29 2015
    Omnicare tops Street 1Q forecasts Apr 29 2015
    Omnicare tops Street 1Q forecasts Apr 29 2015
    Omnicare Reports First-Quarter 2015 Financial Results; Company Updates Full-Year 2015 Guidance Apr 29 2015
    OMNICARE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Apr 29 2015
    Omnicare Reports First-Quarter 2015 Financial Results; Company Updates Full-Year 2015 Guidance Apr 29 2015
    Q1 2015 Omnicare Inc Earnings Release - Before Market Open Apr 29 2015
    Omnicare Reports First-Quarter 2015 Financial Results; Company Updates Full-Year 2015 Guidance Apr 29 2015
    Five things you need to know today, and the New York Times' Cincinnati love fest continues Apr 27 2015
    Five things you need to know today, and after last night I have no doubt Amazon will rule the world Apr 24 2015
    Omnicare at Almost $10 Billion Still Worth It for CVS: Real M&A Apr 24 2015
    Omnicare downgraded by RBC Capital Mkts Apr 24 2015
    One Factor Driving Omnicare (OCR) Stock Up Today Apr 23 2015
    Omnicare Exploring Sale of Nursing Home Drug Supplier Apr 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK